FDA Import Refusal SCS-2832741-4/20003/1 — JIANGSU VANCHING PHARMACEUTICALS
The FDA refused shipment SCS-2832741-4/20003/1 from JIANGSU VANCHING PHARMACEUTICALS (China) on Aug 6, 2025. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Aug 6, 2025
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75